Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The main purpose of this study is to evaluate the safety and effectiveness of the study drug known as LY2623091 in participants with high blood pressure.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Have a history of hypertension.
If participants are naïve to treatment of hypertension, or have not been treated with any antihypertensive medications within the 30 days immediately prior to screening:
If participants are currently being treated for hypertension:
Have a body mass index (BMI) ≥18.5 and <40 kilograms/m^2.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
304 participants in 7 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal